RENEWI PLC — M&A Activity 2024

Dec 27, 2024

FORM 8 (OPD) - RENEWI PLC

Released : 11 Dec 2024 12:00:00

RNS Number : 5912P Renewi PLC 11 December 2024

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:	Renewi plc
(b) Owner or controller of interests and short
positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient. For a trust, the trustee(s), settlor and
beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose	Renewi plc
relevant securities this form relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:	10 December 2024
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the	N/A
discloser making disclosures in respect of any
other party to the offer?
If it is a cash offer or possible cash offer, state
"N/A"

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:	Ordinary Shares of £1.00 each par value
	Interests		Short positions
	Number	%	Number	%

12/24/24, 12:41 PM Form 8 (OPD) - Renewi PLC

(1) Relevant securities owned	Nil	0	Nil	0
and/or controlled:
(2) Cash-settled derivatives:	Nil	0	Nil	0
(3) Stock-settled derivatives	Nil	0	Nil	0
(including options) and
agreements to purchase/sell:
	Nil	0	Nil	0
TOTAL:

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

Class of relevant security in relation to	Nil
which subscription right exists:
Details, including nature of the rights	N/A
concerned and relevant percentages:

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

a) Holdings of directors of Renewi plc:

Name	Number of Ordinary Shares held	Percentage of total issued share capital (to two decimal places)	Beneficial Owner/ Controller
Otto de Bont	391,841	0.48	Otto de Bont
Annemieke den Otter	87,240	0.10	Annemieke den Otter
Luc Sterckx	28,500	0.03	Luc Sterckx and Christine Stymans*
Total:	507,581	0.63

*Close relative of Luc Sterckx

b) Options and awards held by directors of Renewi plc:

	Number of
	Renewi
	shares	Date of	Date of	Date of	Exercise
Name	awarded	grant	vesting	expiry	price

Deferred Annual Bonus Plan
Otto de Bont	16,272	22 June	22 June	22 June	Nil
		2020	2025	2025
	22,798	16 June	16 June	16 June	Nil
		2022	2025	2025
	24,241	19 June	19 June	19 June	Nil
		2023	2026	2026
	14,644	5 June	5 June 2027	5 June 2027	Nil
		2024
Annemieke den	18,302	19 June	19 June	19 June	Nil
Otter		2023	2026	2026
	12,438	5 June	5 June 2027	5 June 2027	Nil
		2024
	Number of
	Renewi
	shares	Date of	Date of	Date of	Exercise
Name	awarded	grant	vesting	expiry	price
LTIP
Otto de Bont	94,931	16 June	16 June	16 June	Nil
		2022	2025	2025
	136,590	19 June	19 June	19 June	Nil
		2023	2026	2026
	109,831	5 June	5 June 2027	5 June 2027	Nil
		2024
Annemieke den	20,432	16 June	16 June	16 June	Nil
Otter		2022	2025	2025
	92,814	19 June	19 June	19 June	Nil
		2023	2026	2026
	74,630	5 June	5 June 2027	5 June 2027	Nil
		2024

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

Date of disclosure:	11 December 2024
Contact name:	Ute Ball
Telephone number:	020 3991 2544

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEEFBLLFZLLLFBK